Retinal Degeneration Clinical Trial
Official title:
Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS
This study aims to assess the impact of the subretinal implant RETINA IMPLANT Alpha AMS on the patient's daily life, using validated activities of daily living and questionnaires.
This study aims to assess the impact of the subretinal implant RETINA IMPLANT Alpha AMS on
the patient's daily life. In addition, the study will provide additional information about
the safety and efficacy of the CE-certified RETINA IMPLANT Alpha AMS. In several studies it
has been shown that patients who received this subretinal implant regain visual function to a
certain extent and that its use is safe. So far, all assessments of patients with the RETINA
IMPLANT Alpha AMS have been done in a controlled environment within the scope of
interventional studies where the benefit in daily life has been assessed anecdotally only.
Currently, there is no standard method available for an objective assessment of the impact of
such devices in daily life of these patients. Hence, the aim of this study is to further
assess the impact in daily life with a combination of already validated and newly developed
assessments and questionnaires.
This study adheres to the tenets of the Declaration of Helsinki.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01432847 -
Cell Collection to Study Eye Diseases
|
||
| Active, not recruiting |
NCT03872479 -
Single Ascending Dose Study in Participants With LCA10
|
Phase 1/Phase 2 | |
| Completed |
NCT00231010 -
Molecular Genetics of Retinal Degenerations
|
||
| Recruiting |
NCT03078309 -
The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients
|
Early Phase 1 | |
| Active, not recruiting |
NCT01736293 -
Natural History of Eye Diseases Related to ABCA4 Mutations
|
||
| Completed |
NCT03318549 -
BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases
|
N/A | |
| Completed |
NCT04919473 -
Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa
|
Phase 1/Phase 2 | |
| Completed |
NCT03321253 -
Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification
|
N/A | |
| Completed |
NCT01497379 -
Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
|
N/A | |
| Recruiting |
NCT04620876 -
Bimodal and Coaxial High Resolution Ophtalmic Imaging
|
N/A | |
| Recruiting |
NCT03592017 -
Performance of Long-wavelength Autofluorescence Imaging
|
N/A | |
| Completed |
NCT03150654 -
The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes
|
N/A | |
| Recruiting |
NCT04545736 -
Oral Metformin for Treatment of ABCA4 Retinopathy
|
Phase 1/Phase 2 | |
| Completed |
NCT00403195 -
Clinical and Pathophysiological Description of Ocular Ischemic Syndrome
|
N/A | |
| Enrolling by invitation |
NCT06167642 -
Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
|
||
| Enrolling by invitation |
NCT02144103 -
Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06289452 -
Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis
|
Early Phase 1 | |
| Recruiting |
NCT02617966 -
Rod and Cone Mediated Function in Retinal Disease
|
||
| Recruiting |
NCT04855045 -
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
|
Phase 2/Phase 3 | |
| Completed |
NCT01399515 -
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
|
Phase 2 |